Kiniksa Pharmaceuticals International (KNSA) Change in Cash (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Change in Cash of $24.4 million for Q1 2026, up 362.97% on a QoQ basis from -$9.3 million in Q4 2025, and up 192.09% year-over-year from $8.3 million in Q1 2025.
Kiniksa Pharmaceuticals International (KNSA) Change in Cash (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International's Change in Cash history runs 10 years deep, the most recent figure standing at $24.4 million for Q1 2026.
- Quarterly Change in Cash rose 192.09% year-over-year to $24.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.8 million (up 104.44% YoY) and the FY2025 annual result came in at -$18.0 million, down 123.78% from the prior year.
- Change in Cash was $24.4 million for Q1 2026 at Kiniksa Pharmaceuticals International, up from -$9.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $86.2 million in Q4 2024 and bottomed at -$59.1 million in Q1 2022.
- A 5-year average of $4.0 million and a median of -$1.9 million in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 1116.6% — and 2024, when it jumped 973.05%.
- Kiniksa Pharmaceuticals International's Change in Cash stood at -$53.0 million in 2022, then surged by 81.39% to -$9.9 million in 2023, then soared by 973.05% to $86.2 million in 2024, then plunged by 110.74% to -$9.3 million in 2025, then jumped by 362.97% to $24.4 million in 2026.
- Business Quant data shows KNSA's Change in Cash at $24.4 million in Q1 2026, -$9.3 million in Q4 2025, and -$17.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 4.82 Bn | 4.36 Bn | 193.47 Mn | 24.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.36 Mn |
| Dec 31, 2025 | -9.26 Mn |
| Sep 30, 2025 | -17.18 Mn |
| Jun 30, 2025 | 34.91 Mn |
| Mar 31, 2025 | -26.45 Mn |
| Dec 31, 2024 | 86.21 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Jun 30, 2024 | -41.81 Mn |
| Mar 31, 2024 | 33.12 Mn |
| Dec 31, 2023 | -9.87 Mn |
| Sep 30, 2023 | 5.26 Mn |
| Jun 30, 2023 | 31.95 Mn |
| Mar 31, 2023 | -42.10 Mn |
| Dec 31, 2022 | -53.05 Mn |
| Sep 30, 2022 | 81.45 Mn |
| Jun 30, 2022 | 30.98 Mn |
| Mar 31, 2022 | -59.15 Mn |
| Dec 31, 2021 | -67.71 Mn |
| Sep 30, 2021 | 22.02 Mn |
| Jun 30, 2021 | 48.10 Mn |